热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　宜明昂科-B（01541）早盘高开，截至发稿，股价上涨3.48%，现报4.76港元，成交额385.48万港元。

　　宜明昂科-B发布公告，IMM2510联合化疗进行非小细胞肺癌（NSCLC）一线治疗的Ib/II期临床试验成功完成首例患者给药。安全性导入期后，公司计划在上述临床试验中招募一线患者，预计最早于2025年下半年发布初步临床数据，包括来自NSCLC一线患者的数据。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.